The online version of this article (doi:10.1186/1477-7819-10-153) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
TN carried out the surgical procedure, designed the report, analyzed all the reports, and drafted the manuscript. YK, HY, and SY carried out the surgical procedure and participated in designing the manuscript. HI performed all examinations and made the diagnosis. NI performed the histological analysis of the surgical specimens and provided histological sections as figures for the manuscript. RM performed the histological analysis of the surgical specimens and analyzed the expression of neurofibromin in the immunohistochemistry. YT participated in designing the report and revised the manuscript for submission. All authors have read and approved the final manuscript.
Patients with neurofibromatosis-1 (NF-1) sometime develop neuroendocrine tumors (NET). Although these NETs usually occur in the duodenum or peri-ampullary region, they occasionally grow in the pancreas (PNET). A 62-year-old man with NF-1 had mild liver dysfunction and was admitted to our hospital for further examination. An abdominal contrast-enhanced computed tomography scan demonstrated a 30-mm tumor in the head of the pancreas. The scan showed an invasion of the tumor into the duodenum, and biopsy under an endoscopic ultrasonography indicated that the tumor was a NET. A subtotal stomach-preserving pancreaticoduodenectomy was performed. Macroscopically, the pancreatic tumor was white and elastic hard. Microscopically, tumor cells were composed of ribbons, cords, and solid nests with an acinus-like structure. The tumor was diagnosed as NET G2 according to the WHO classification (2010). The product of theNF-1 gene, i.e., neurofibromin, was weakly positive in the tumor cells, suggesting that the tumor was induced by a mutation in the NF-1 gene. This is the seventh case of PNET arising in NF-1 patients worldwide.
Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL: Neurofibromatosis type 1 revisited. Pediatrics. 2009, 23: 124-133. CrossRef
Klein A, Clemens J, Cameron J: Periampullary neoplasms in von Recklinghausen's disease. Surgery. 1989, 106: 815-819. PubMed
Saurenmann P, Binswanger R, Maurer R, Stamm B, Hegglin J: Somatostatin-producing endocrine pancreatic tumor in Recklinghausen's neurofibromatosis. Schweiz Med Wochenschr. 1987, 117: 1134-1139. PubMed
Thannberger P, Wilhelm JM, Derragui A, Saraceni O, Kieffer P: Von Recklinghausen's disease associated with pancreatic somatostatinoma. Presse Med. 2001, 30: 1741-1743. PubMed
Fujisawa T, Osuga T, Maeda M, Sakamoto N, Maeda T, Sakaguchi K, Onishi Y, Toyoda M, Maeda H, Miyamoto K, Kawaraya N, Kusumoto C, Nishigami T: Malignant endocrine tumor of the pancreas associated with von Recklinghausen's disease. J Gastroenterol. 2002, 37: 59-67. 10.1007/s535-002-8135-x. CrossRefPubMed
Perren A, Wiesli P, Schmid S, Montani M, Schmitt A, Schmid C, Moch H, Komminoth P: Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient. Am J Surg Pathol. 2006, 30: 1047-1051. 10.1097/00000478-200608000-00018. CrossRefPubMed
Bosman FT, Carneiro F, Hruban RH, Theise ND: WHO Classificaion of Tumors of the Digestive System (World Health Organization Classification of Tumours). 2010, Lyon: IARC Press
Sobin LH, Wittekind C, Gospodarowicz M: TNM classification of malignant tumors (UICC). 2009, New York: Wiley-Blackwell, 7
Speel EJ, Richter J, Moch H, Egenter C, Saremaslani P, Rütimann K, Zhao J, Barghorn A, Roth J, Heitz PU, Komminoth P: Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. Am J Pathol. 1999, 155: 1787-1794. 10.1016/S0002-9440(10)65495-8. PubMedCentralCrossRefPubMed
Yamamoto H, Tobo T, Nakamori M, Imamura M, Kojima A, Oda Y, Nakamura N, Takahira T, Yao T, Tsuneyoshi M: Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q. J Cancer Res Clin Oncol. 2009, 135: 791-798. 10.1007/s00432-008-0514-z. CrossRefPubMed
Duong TA, Sbidian E, Valeyrie-Allanore L, Vialette C, Ferkal S, Hadj-Rabia S, Glorion C, Lyonnet S, Zerah M, Kemlin I, Rodriguez D, Bastuji-Garin S, Wolkenstein P: Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980–2006 in france. Orphanet J Rare Dis. 2011, 6: 18-10.1186/1750-1172-6-18. PubMedCentralCrossRefPubMed
- A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1
- BioMed Central
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II